These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8105217)

  • 1. Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis.
    Smith GC; Kenna JG; Harrison DJ; Tew D; Wolf CR
    Lancet; 1993 Oct; 342(8877):963-4. PubMed ID: 8105217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.
    Kitteringham NR; Kenna JG; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):379-86. PubMed ID: 8554940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
    Eliasson E; Kenna JG
    Mol Pharmacol; 1996 Sep; 50(3):573-82. PubMed ID: 8794896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.
    Satoh H; Martin BM; Schulick AH; Christ DD; Kenna JG; Pohl LR
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):322-6. PubMed ID: 2911577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase.
    Martin JL; Kenna JG; Martin BM; Thomassen D; Reed GF; Pohl LR
    Hepatology; 1993 Oct; 18(4):858-63. PubMed ID: 8406360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.
    Knight TL; Scatchard KM; Van Pelt FN; Kenna JG
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1325-33. PubMed ID: 7932186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for antibodies associated with halothane hepatitis.
    Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
    Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists.
    Njoku DB; Greenberg RS; Bourdi M; Borkowf CB; Dake EM; Martin JL; Pohl LR
    Anesth Analg; 2002 Feb; 94(2):243-9, table of contents. PubMed ID: 11812677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
    Komurasaki R; Imaoka S; Tada N; Okada K; Nishiguchi S; Funae Y
    Drug Metab Pharmacokinet; 2010; 25(1):84-92. PubMed ID: 20208391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens.
    Gut J; Christen U; Frey N; Koch V; Stoffler D
    Toxicology; 1995 Mar; 97(1-3):199-224. PubMed ID: 7716787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
    Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
    J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis.
    Kenna JG; Neuberger J; Williams R
    Hepatology; 1988; 8(6):1635-41. PubMed ID: 3192177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72.
    Pumford NR; Martin BM; Thomassen D; Burris JA; Kenna JG; Martin JL; Pohl LR
    Chem Res Toxicol; 1993; 6(5):609-15. PubMed ID: 8292737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia.
    Vergani D; Tsantoulas D; Eddleston AL; Davis M; Williams R
    Lancet; 1978 Oct; 2(8094):801-3. PubMed ID: 81359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane and the liver--the present situation.
    Neuberger J
    J Clin Pharm Ther; 1987 Oct; 12(5):269-71. PubMed ID: 3680400
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of anticonvulsant agents on halothane-induced liver injury in human subjects and experimental animals.
    Nomura F; Hatano H; Ohnishi K; Akikusa B; Okuda K
    Hepatology; 1986; 6(5):952-6. PubMed ID: 3093358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitis.
    Bird GL; Williams R
    J Hepatol; 1989 Nov; 9(3):366-73. PubMed ID: 2607125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of liver microsomal beta-glucuronidase from hepatocytes in vitro and in vivo by organophosphates and hepatotoxic agents.
    Satoh T
    J Toxicol Sci; 1991 Feb; 16 Suppl 1():133-42. PubMed ID: 1920540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of halothane toxicity: novel insights.
    Gut J; Christen U; Huwyler J
    Pharmacol Ther; 1993; 58(2):133-55. PubMed ID: 8415876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.
    Vergani D; Mieli-Vergani G; Alberti A; Neuberger J; Eddleston AL; Davis M; Williams R
    N Engl J Med; 1980 Jul; 303(2):66-71. PubMed ID: 6991940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.